Real-time enrollment status for this relapsed solid tumor malignancies clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 7:59 AM UTC
| NCT Number | NCT07672483 |
| Recruiting Status | Recruiting |
| Condition | Relapsed Solid Tumor Malignancies |
| Phase | PHASE1 |
| Target Enrollment | 95 participants |
| Active Locations | 1 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | October 14, 2026 (Yesterday) |
As of October 15, 2026: Clinical trial NCT07672483 is currently recruiting participants. This phase1 study for relapsed solid tumor malignancies is actively seeking new participants at 1 location across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07672483 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07672483 was last updated Yesterday (October 14, 2026). HelloStudys verifies this status automatically.